ACUR
Acura Pharmaceuticals
ACUR
ACUR
Delisted
ACUR was delisted on the 22nd of February, 2017.
22 hedge funds and large institutions have $9.76M invested in Acura Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
19% less funds holding
Funds holding: 27 → 22 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Holders
22
Holding in Top 10
1
Calls
$16K
Puts
$1K
Top Buyers
| 1 | +$2.41M | |
| 2 | +$1.75M | |
| 3 | +$101K | |
| 4 |
Renaissance Technologies
New York
|
+$31.3K |
| 5 |
SIM
Spark Investment Management
New York
|
+$26.7K |
Top Sellers
| 1 | -$45K | |
| 2 | -$42.3K | |
| 3 | -$24K | |
| 4 |
LC
Lincoln Capital
Lincoln,
Nebraska
|
-$21K |
| 5 |
CA
Cortland Associates
St Louis,
Missouri
|
-$21K |